| Literature DB >> 35270196 |
Valentina Roviello1, Melinda Gilhen-Baker2, Caterina Vicidomini3, Giovanni N Roviello3.
Abstract
Humanity may benefit greatly from intact riverine ecosystems not only because they supply water to be used in the most common human activities, but also for the effects that clean rivers can have on human health. Herein, we used a computational approach to show that some phytochemicals produced by riparian plants as secondary metabolites, which are naturally released into river waters, can have therapeutic properties. These include antipsoriatic activities which we demonstrated in silico by modelling the interaction of apiin, guanosine and hyperoside, a few main river plant metabolites, with NF-kB, IL-17 and IL-36, which are recognized targets involved in psoriasis disease. In particular, we found that apiin and hyperoside are endowed with docking energies and binding affinities which are more favorable than the known reference inhibitors of the three protein targets whilst, in silico, guanosine shows comparable activity with respect to the inhibitors of IL-36 and NF-kB. The low skin permeation (logKp < -8) we predicted for apiin and hyperoside led us to hypothesize their possible utilization as topic antipsoriatic therapeutics, and in particular after PAINS (pan-assay interference compounds) score evaluation, we reached the conclusion that apiin, with no predicted tendency to react nonspecifically with the numerous targets involved in the biological cellular pathways, is particularly interesting for the desired therapeutic application.Entities:
Keywords: anti-psoriatic drug; environmental health; molecular docking; phytomedicine; plant metabolites
Mesh:
Substances:
Year: 2022 PMID: 35270196 PMCID: PMC8909116 DOI: 10.3390/ijerph19052502
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Chemical structures of some of the plant metabolites (a–e) detected in river waters. Note how the most abundant apiin (c), guanosine (d) and hyperoside (e) subjected to the in silico analysis of the current work are shown in the rectangular box, while isofraxidin (a), contained in an antipsoriatic treatment, and quercetin (b), with known antipsoriatic activity and in turn obtained after acidic hydrolysis of hyperoside, are represented in the upper part of the figure.
Ligand/NF-kB complexation: HDOCK docking scores (for the top ranked poses and averaged on the Top-1–10 poses). The main amino acids involved in the ligand/protein complexes for the Reference compound and each plant metabolite are reported in the last column.
| HDOCK Score a for the Top-1 Ranked Pose | HDOCK Score a—Averaged on the Top 10 Poses ± SD | Main Residues Involved in the Ligand-Protein Complex | |
|---|---|---|---|
| Reference compound b | −253.91 | −210.047 ± 25.277 | Tyr55, Ser220, Asn227, Lys252, Gln284 |
| Apiin | −311.83 | −275.535 ± 24.457 | Gly50, Ser220, Asn227, Lys252, Gln284 |
| Guanosine | −210.04 | −181.209 ± 16.489 | Ser220, Lys252, Gln284 |
| Hyperoside | −310.81 | −286.252 ± 10.385 | Ser220, Asn227, Lys252, Gln284 |
a The docking energy scores. b Dexanabinol [26].
Ligand/IL-17 complexation: HDOCK docking scores (for the top ranked poses and averaged on the Top-1–10 poses). The main amino acids involved in the ligand/protein complexes for the Reference compound and each plant metabolite are reported in the last column.
| HDOCK Score a for the Top-1 Ranked Pose | HDOCK Score a—Averaged on the Top 10 Poses ± SD | Main Residues Involved in the Ligand-Protein Complex | |
|---|---|---|---|
| Reference compound b | −234.41 | −213.715 ± 10.023 | Asn36, Pro37, |
| Apiin | −249.73 | −235.954 ± 9.371 | Met166,Ser167, Trp193, Asn194 |
| Guanosine | −183.72 | −162.772 ± 10.651 | Asp58, His131, Lys135, Pro136 |
| Hyperoside | −248.10 | −224.287 ± 10.313 | Met166, Ser167, Trp193, Asn194, Tyr62, Pro63, Val65 |
a The docking energy scores. b (4S,20R)-7-chloro-N-methyl-4-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-3,18-dioxo-2,19-diazatetracyclo[20.2.2.1_6,10_.1_11,15_]octacosa-1(24),6(28),7,9,11(27),12,14,22,25-nonaene-20-carboxamide.
Ligand/IL-36 complexation: HDOCK docking scores (for the top ranked poses and averaged on the Top-1–10 poses). The main amino acids involved in the ligand/protein complexes for the Reference compound and each plant metabolite are reported in the last column.
| HDOCK Score a for the Top-1 Ranked Pose | HDOCK Score a—Averaged on the Top 10 Poses ± SD | Main Residues Involved in the Ligand-Protein Complex | |
|---|---|---|---|
| Reference compound b | −137.72 | −125.561 ± 5.461 | Arg121, Lys123, Val58, Leu165, Ile27 |
| Apiin | −171.43 | −156.13 ± 6.49 | Arg121, Lys123, Leu165, Asn166 |
| Guanosine | −115.74 | −112.396 ± 3.126 | Lys123, Leu165, Asn166 |
| Hyperoside | −145.44 | −140.679 ± 2.929 | Arg121, Lys123, Leu165, Leu151 |
a The docking energy scores. b (2S)-2-{[4-(3-amino-4-methylphenyl)-6-methylpyrimidin-2-yl]oxy}-3-methoxy-3,3-diphenylpropanoic acid.
Figure 2HDOCK scoring of complexes of the three protein targets (NF-kB, IL-17 and IL-36) involved in psoriasis investigated in our study with the plant metabolites hyperoside, guanosine, apiin and their respective reference inhibitors. Note how the scores for the top-ranked (Top-1) poses are presented in the left side of the figure, while the means (considering the values for poses Top1–10) with the respective Standard Deviations are shown on the right.
Figure 3Structure representations of the complexes NF-kB/hyperoside (left), IL-17/apiin (middle), and IL-36/apiin (right) obtained by us after molecular docking. Note how plant metabolites are represented in yellow.